Marc Kozin

Executive Profile Marc D. Kozin Lead Director, UFP Technologies, Inc. Age Total Calculated Compensation This person is connected to 7 Board Members in 7 organization across 9 different industries. See Board Relationships 57 $72,500 As of Fiscal Year 2017 Background Mr. Marc D. Kozin, M.B.A. was an Independent Director of Endocyte, Inc. since July 25, 2012 December 21, 2018. Mr. Kozin has been a Director Dicerna Pharmaceuticals, Inc., since January 24, 2019. was a Senior Advisor to L.E.K. Consulting, a global strategy consulting firm, since July 2011. Mr. Kozin served as the President of the North American practice for L.E.K. Consulting LLC, from 1996 to January 1, 2012. He served L.E.K. Consulting in various capacities since July 1987. He is a career strategy consultant with 30 years of experience, both domestically and internationally, advising senior executives in life sciences to identify new growth opportunities, pursue highly-profitable mergers and acquisitions and support sustained growth. He also has deep industry expertise advising biopharmaceutical, life sciences and medtech companies. He was integral to the merger of L.E.K. and Alcar in 1993 and helped found its Boston office in 1987 and oversaw the growth of the firm's U.S. operations. During his tenure at L.E.K., Mr. Kozin advised senior executives in life sciences and other industries to help them identify new growth opportunities, build value, pursue highly-profitable merger and acquisition activities and support sustained growth. He worked at Chase Econometrics and Resource Strategies, where he specialized in providing advice to commodity industry participants. Mr. Kozin has been an Independent Director of UFP Technologies, Inc. since June 8, 2006. He has been Lead Director of UFP Technologies, Inc. since January 2015. He has been a Director of Precision Therapeutics, Inc., since November 2011. He has been a Director of Helomics Corporation, CrunchTime!, Inc. since December 2002 and Brandwise, Inc., since December 2002. He has been a Member of the Board of Governors at New England Medical Center since February 2000. He serves as a Director of Medical Simulation Corporation and DukeEngage. Mr. Kozin serves as a Member of the Strategic Advisory Board of HealthCare Royalty Partners. He has been an Independent Director of Flex Pharma, Inc. since October 2014. He serves as an Independent Director at Frequency Therapeutics, Inc. He serves as a Director of OvaScience, Inc. since January 10, 2014. He served as a Director of Dyax Corp. from October 16, 2012 to January 22, 2016. He served as a Director of Lynx Therapeutics Inc. since July 2002. He served as a Director at Assurance Medical, Inc. from October 1999 to July 2001. In 2002 Consulting Magazine named Mr. Kozin one of the 25 most influential consultants in recognition of his leadership and results for clients. He holds a B.A., magna cum laude, in Economics from Duke University and an M.B.A. with distinction from The Wharton School, University of Pennsylvania. Collapse Detail Corporate Headquarters 100 Hale Street Newburyport, Massachusetts 01950 United States Phone: 978-352-2200 Fax: 978-352-5616